IN2015DN02376A - - Google Patents

Download PDF

Info

Publication number
IN2015DN02376A
IN2015DN02376A IN2376DEN2015A IN2015DN02376A IN 2015DN02376 A IN2015DN02376 A IN 2015DN02376A IN 2376DEN2015 A IN2376DEN2015 A IN 2376DEN2015A IN 2015DN02376 A IN2015DN02376 A IN 2015DN02376A
Authority
IN
India
Prior art keywords
crystal
luliconazole
plane
solubility
improving
Prior art date
Application number
Other languages
English (en)
Inventor
Takaaki; Masuda
Nohyaku Co Ltd Nihon
Original Assignee
Pola Pharma Inc
Nohyaku Co Ltd Nihon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pola Pharma Inc, Nohyaku Co Ltd Nihon filed Critical Pola Pharma Inc
Publication of IN2015DN02376A publication Critical patent/IN2015DN02376A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IN2376DEN2015 2012-09-14 2012-11-02 IN2015DN02376A (cs)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012202516 2012-09-14
PCT/JP2012/079050 WO2014041708A1 (en) 2012-09-14 2012-11-02 Crystal having crystal habits and pharmaceutical composition obtained by processing the crystal

Publications (1)

Publication Number Publication Date
IN2015DN02376A true IN2015DN02376A (cs) 2015-09-04

Family

ID=47278492

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2376DEN2015 IN2015DN02376A (cs) 2012-09-14 2012-11-02

Country Status (7)

Country Link
US (1) US9199977B2 (cs)
EP (1) EP2895479A1 (cs)
JP (1) JP5453559B1 (cs)
CN (1) CN104619703A (cs)
IN (1) IN2015DN02376A (cs)
RU (1) RU2603963C2 (cs)
WO (1) WO2014041708A1 (cs)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5688406B2 (ja) 2009-04-09 2015-03-25 株式会社ポーラファルマ 抗真菌医薬組成物
WO2010117089A2 (en) 2009-04-09 2010-10-14 Pola Pharma Inc. Antimycotic pharmaceutical composition
EP2470178B1 (en) 2009-08-25 2018-10-17 Pola Pharma Inc. Antimycotic pharmaceutical composition
US8962669B2 (en) 2010-06-11 2015-02-24 Pola Pharma Inc. Antimycotic pharmaceutical composition
JP5460797B1 (ja) 2012-09-14 2014-04-02 株式会社ポーラファルマ アミド誘導体及び安定性指標としてのその使用
WO2014042231A1 (en) 2012-09-14 2014-03-20 Pola Pharma Inc. Crystal and pharmaceutical preparation containing the same crystal
WO2014041846A1 (en) 2012-09-14 2014-03-20 Pola Pharma Inc. Use of surface free energy for differential evaluation of crystal, crystal evaluated on basis of surface free energy as index, and phrmaceutical composition prepared by containing the crystal
JP5589110B1 (ja) 2013-03-08 2014-09-10 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
JP5680161B1 (ja) * 2013-09-06 2015-03-04 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
JP5587488B1 (ja) 2013-12-12 2014-09-10 株式会社ポーラファルマ ルリコナゾールを含有する製剤の評価方法及び指標物質
JP5951864B1 (ja) * 2015-06-05 2016-07-13 株式会社ポーラファルマ 抗ジアルジア剤
JP2017101009A (ja) * 2015-12-04 2017-06-08 株式会社ポーラファルマ 抗アカントアメーバ剤及びその製造法
JP6085706B1 (ja) * 2016-03-31 2017-02-22 株式会社ポーラファルマ 抗トリトリコモナス剤

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3081766B2 (ja) 1994-05-06 2000-08-28 東興薬品工業株式会社 角質貯留型抗真菌外用組成物
CH692045A5 (de) * 1995-07-08 2002-01-15 Nihon Nohyaku Co Ltd Fungizide Mittel, eine Verbindung hierfür, Verfahren zu ihrer Herstellung und Verfahren zu ihrer Verwendung.
JP3278738B2 (ja) 1995-07-08 2002-04-30 日本農薬株式会社 抗真菌剤
JP2002114680A (ja) 2000-07-31 2002-04-16 Nippon Nohyaku Co Ltd 抗真菌剤
CA2645070C (en) * 2006-03-08 2014-02-04 Nihon Nohyaku Co., Ltd. Pharmaceutical composition for external use
US8058303B2 (en) 2006-03-08 2011-11-15 Nihon Nohyaku Co, Ltd Pharmaceutical composition for external use
EP2025337B1 (en) 2006-03-08 2014-09-10 Nihon Nohyaku Co., Ltd. Pharmaceutical composition for external use
JP5453093B2 (ja) 2007-09-05 2014-03-26 株式会社ポーラファルマ 抗真菌医薬組成物
WO2009031642A1 (ja) 2007-09-05 2009-03-12 Pola Pharma Inc. 医薬組成物
JP5345937B2 (ja) 2007-09-05 2013-11-20 株式会社ポーラファルマ 抗真菌組成物
CN102395274B (zh) * 2009-02-13 2014-03-12 托派卡医药股份有限公司 抗真菌制剂
WO2010117089A2 (en) 2009-04-09 2010-10-14 Pola Pharma Inc. Antimycotic pharmaceutical composition
JP5688406B2 (ja) 2009-04-09 2015-03-25 株式会社ポーラファルマ 抗真菌医薬組成物
EP2470178B1 (en) 2009-08-25 2018-10-17 Pola Pharma Inc. Antimycotic pharmaceutical composition
US8962669B2 (en) 2010-06-11 2015-02-24 Pola Pharma Inc. Antimycotic pharmaceutical composition
CN103012385B (zh) * 2012-02-17 2015-07-08 山东威智医药工业有限公司 卢立康唑的晶型及其制备方法
WO2014041846A1 (en) 2012-09-14 2014-03-20 Pola Pharma Inc. Use of surface free energy for differential evaluation of crystal, crystal evaluated on basis of surface free energy as index, and phrmaceutical composition prepared by containing the crystal
WO2014042231A1 (en) 2012-09-14 2014-03-20 Pola Pharma Inc. Crystal and pharmaceutical preparation containing the same crystal
WO2014042043A1 (en) 2012-09-14 2014-03-20 Pola Pharma Inc. Pharmaceutical composition containing luliconazole
JP5460797B1 (ja) 2012-09-14 2014-04-02 株式会社ポーラファルマ アミド誘導体及び安定性指標としてのその使用
JP5589110B1 (ja) 2013-03-08 2014-09-10 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物

Also Published As

Publication number Publication date
US20150183766A1 (en) 2015-07-02
JP5453559B1 (ja) 2014-03-26
WO2014041708A1 (en) 2014-03-20
RU2603963C2 (ru) 2016-12-10
CN104619703A (zh) 2015-05-13
EP2895479A1 (en) 2015-07-22
JP2014074008A (ja) 2014-04-24
US9199977B2 (en) 2015-12-01
RU2015109127A (ru) 2016-11-10

Similar Documents

Publication Publication Date Title
IN2015DN02376A (cs)
IN2014CN02639A (cs)
MY165759A (en) Pull-on diaper
IN2015DN02929A (cs)
NZ719568A (en) Crystals of diazabicyclooctane derivative and production method for crystals of diazabicyclooctane derivative
MX2015002487A (es) Proceso para la preparacion de teneligliptina.
IN2013MU00646A (cs)
NZ708371A (en) Methods for treating pruritus
GEP201706626B (en) Synthesis of (s)-nifuratel
IN2013DE00266A (cs)
EP2990509A4 (en) METHOD FOR GROWING ß-Ga2O3-BASED SINGLE CRYSTAL
ZA201505194B (en) Plant growth regulating compounds
AU2014371081A1 (en) Polyoxalates and a Process for the Production Thereof
IN2013MU03070A (cs)
PH12016501183A1 (en) Novel compound for treatment of severe hypoglycemia
AU2013347232A8 (en) 3-Aminocyclopentane carboxamide derivatives
PH12016501184A1 (en) Novel compound for treatment of severe hypoglycemia
PH12016501182A1 (en) Novel compound for treatment of severe hypoglycemia
IN2013MU04056A (cs)
MX369174B (es) Proceso para la preparación de un compuesto.
IN2013CH05282A (cs)
IN2013MU03755A (cs)
MY168058A (en) Optical transducer with integrated feedthrough
MY185479A (en) Process for preparing heonone (meth)acrylate
MX361673B (es) Procedimiento para la preparación de intermediarios de ácido borónico.